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The objective of this study is to determine the eﬀects of 12 weeks of lavender aromatherapy on self-reported sleep and heart rate
variability (HRV) in the midlife women with insomnia. Sixty-seven women aged 45–55 years, with a CPSQI (Chinese version
of Pittsburgh Sleep Quality Index) greater than 5, were recruited from communities in Taiwan. The experimental group (n =
34) received lavender inhalation, 20min each time, twice per week, for 12 weeks, with a total of 24 times. The control group
(n = 33) received health education program for sleep hygiene with no intervention. The study of HRV was analyzed by time-
and frequency-domain methods. Signiﬁcant decrease in mean heart rate (HR) and increases in SDNN (standard deviation of the
normal-to-normal (NN) intervals), RMSDD (square root of the mean squared diﬀerences of successive NN intervals), and HF
(high frequency) of spectral powers analysis after lavender inhalation were observed in the 4th and 12th weeks of aromatherapy.
The total CPSQI score of study subjects was signiﬁcantly decreased in the experimental group (P<0.001), while no signiﬁcant
diﬀerence was observed across the same time period (P = 0.776) in the control group. Resting HR and HRV measurements at
baseline1monthand3monthsafterallocationshowednosigniﬁcantdiﬀerencebetweentheexperimentalandcontrolgroups.The
study demonstrated that lavender inhalation may have a persistent short-term eﬀect on HRV with an increase in parasympathetic
modulation. Women receiving aromatherapy experienced a signiﬁcant improvement in sleep quality after intervention. However,
lavender aromatherapy does not appear to confer beneﬁt on HRV in the long-term followup.
1.Introduction
Subjective reports of diﬃcult sleeping are prevalent in
middle-aged women undergoing the menopausal transition.
Sleep problems are reported in 39–47% of perimenopausal
women, and 35–60% of postmenopausal women from the
data presented at the NIH State-of-the-Science Conference
on Management of Menopause-Related Symptoms [1]. In
Taiwan, 46% of the middle-aged women felt dissatisﬁed with
their sleep in a community-based study [2]. The incidence
is consistent with prior studies in other patient populations,
and the underlying mechanisms of poor sleep quality among
these women were related to anxiety [2]. Sleep disturbances
havebeenconsideredasanaturalpartoftheperimenopausal
process in Taiwan [3–5]. Perimenopausal women generally
believe that their sleep problems will subside as they
pass through menopause transition period. Therefore, they
tended to seek self-help strategies or complementary and
alternative medicine (CAM) before resorting to western
medicine [3–5].
Among the CAM, aromatherapy has been widely used to
modify mood and sleep [6]. Aroma inhalation of lavender,
chamomile, and ylang-ylang induces a state of mind con-
ducive to sleep. Short-term inhalation of lavender oil has
been used as a sleep aid [6]. In a single-blinded, randomized
pilot study, Lewith and colleagues investigated the eﬃcacy
of lavender essential oil on insomnia in 10 volunteers and
discovered that the lavender oil created an improvement in
the sleeping quality more eﬀectively than sweet almond oil
in the control group [7]. Using a placebo, a control, and2 Evidence-Based Complementary and Alternative Medicine
a treatment, Goel and colleagues found that lavender was
able to increase the percentage of deep or slow-wave sleep
in both men and women [8]. Lavender also was found
to increase stage 2 (light) sleep and decrease rapid eye
movement (REM) sleep and the amount of time to wake
up after ﬁrst falling asleep (waking up after sleep onset
latency) in women, with opposite eﬀects in men. It was
concluded that lavender may provide a mild sedation to
promote sleep [7, 8]. However, there is insuﬃcient evidence
from the current investigations to prove direct hypnotic
eﬀect of lavender oil in treating insomnia [9, 10].
On the other hand, there are evidences for the eﬀec-
tiveness of lavender in the treatment of anxiety in humans
[11]. In a single-blinded, randomized pilot study, Lehrner
and colleagues found lavender odor exposure to be eﬀective
in relieving anxious mood in dental patients who underwent
a stressful procedure [12]. Kuroda and colleagues examined
the sedative eﬀects of (R)-(−)-linalool, the main component
of both jasmine tea and lavender, on moods and autonomic
nerve activity (ANS) [13]. They found that it produced
calm and vigorous mood state and elicited a signiﬁcant
decreaseinheartrateandanincreaseinHF(high-frequency)
component when compared with the controls [13]. To
examine whetherthe odor is required forlavender toexert its
anxiolytic eﬀects, Bradley and colleagues tested the eﬃcacy
of lavender administered orally. They showed that lavender
capsules have beneﬁcial eﬀects in relieving mild anxiety
with signiﬁcantly increased heart rate variability (HRV) in
females but not in males [14] .T h e s es t u d i e sd e m o n s t r a t e d
that lavender’s anxiolytic and stress-relieving eﬀects might
manifest as modulation of HRV.
Most of the published data on the physiological eﬀects
of lavender were tested only in a short duration [11–14].
Therefore, the purpose of this study was to evaluate the
eﬃcacy of lavender aromatherapy on HRV before and after
12 weeks of treatment in midlife women with insomnia. We
hypothesized that lavender aromatherapy would aﬀect both
autonomic modulations and sleep quality after a follow-up
period of 3 months.
2. Methods
2.1. Subjects. This was a prospective study conducted from
November 2007 to June 2008. All study procedures were
approved by the committee at the National Taipei College
of Nursing. Volunteers were recruited voluntarily from
communitiesinTaipeiunderahealthcareprogramregarding
sleep hygiene. All participants met the following criteria: (1)
agebetween45and55years;(2)consciousclearandavailable
verbal communication; (3) no symptoms of dysosmia; (4)
currently not receiving any hormone-replacement therapy.
All potential subjects were screened for sleep quality with
a Chinese version of the Pittsburgh Sleep Quality Index
(CPSQI). The CPSQI has been demonstrated to be a psy-
chometricallysoundmeasureofsleepqualitywithacceptable
test-retest reliability over a 14- to 21-day interval with a
coeﬃcient of 0.85 for all subjects and 0.77 for primary
insomniacs [15]. A CPSQI global score of greater than 5
yielded a sensitivity of 98% and a speciﬁcity of 55% as a
marker for poor sleep in primary insomniacs versus controls
[15]. A total of 67 midlife women who met the above criteria
with a CPSQI greater than 5 were recruited. They were
randomly assigned to the experimental group (n = 34)
and the control group (n = 3 3 )b a s e do nr e g i s t e rc o d e
entry by a computer. The control group did not receive
any intervention. Written consent was obtained before their
participation in the study.
2.2. Procedures. All studies were performed in the evening
after a regular work between 17:00 and 23:00 hours. The
participants were required to abstain from drinking caf-
feinated or alcohol-containing beverage at least 3h prior
to testing. All experiments were conducted in a bright and
q u i e tr o o m ;t h ea m b i e n tt e m p e r a t u r ew a sk e p ta t2 2 – 2 5 ◦C.
Subjects were in a sitting position, providing easy access
to attach the electrodes, and were encouraged to relax.
After relaxing in a comfortable chair with arm supports for
10min, aromatherapy was carried out by inhalation after
instilling 0.25c.c. essential lavender oil (Australian Certiﬁed
Organic Pty Ltd, Brisbane, Australia) and 50c.c. of water
into an ultrasonic ionizer aromatherapy diﬀuser (Heavenly
Scent, YHL International Co., Ltd, Taipei, Taiwan). They
were kept at a distance of 10–15cm away from the diﬀuser,
and the inhalation lasted for 20min each time. Participants
in the aromatherapy arm received a 12-week course of
twice a week with a total of 24 times. Control studies
without aromatherapy were performed in an environment as
described above in the experimental group. A ﬂow diagram
for collecting data is shown in Figure 1.
2.3.HeartRateVariability(HRV)Analysis. Thesubjectswere
instructed to avoid strenuous physical activity and alcohol
and coﬀee intake 24h before the measurement. Before
recording the HRV, the participants practiced controlling
their breathing rhythm to follow the metronome. During
the HRV recording, participants were resting in a sitting
position and breathing in a controlled rate of 12–15 breaths
per min. After 10min of rest in a sitting position, an initial
measurement of HRV was performed. HRV was recorded in
the sitting position using the heart rate variability analyzer
(SA-3000P, Medicore Co., Ltd, Seoul, Korea). The sensor
of HRV was clipped on the index ﬁnger (second ﬁnger) of
the left hand. The subjects were asked to keep silence and
stay inactive during the measurement. HRV measurement
was performed at the baseline measurement, in the 4th
and after the 12th weeks of follow-up period in both
experimental and control groups. In the experimental group,
H R Vm e a s u r e m e n t sw e r ep e r f o r m e db e f o r ea n d1 0m i na f t e r
aromatherapy in the 4th and 12th weeks of the treatment.
HRV analysis was performed according to the guidelines
of the Task Force of the European Society of Cardiology
[16]. Time domain measures quantify the mean heart rate
(HR) and SDNN (ms), that is, the standard deviation of the
normal-to-normal (NN) intervals: RMSSD (ms), that is, the
square root of the mean squared diﬀerences of successive
NN intervals. These measures are considered to be indices ofEvidence-Based Complementary and Alternative Medicine 3
Randomized allocation
67 female volunteers with primary
insomnia were recruited with CPSQI ≥ 5
34 assigned to aromatherapy
twice a week for 12 weeks 33 assigned to control group
HRV measured at the
initial evaluation and
repeated one month
after allocation
Dropped out,
N = 3 due to missed
treatment sessions
N = 2 due to missed
measurements
Dropped out,
N = 1 due to missed
measurements
N = 1d u et o
hypertension
29 received followup HRV and
CPSQI 3 months after allocation
31 received followup HRV and
CPSQI 3 months after allocation
HRV measurements before and
after 20 minutes of aromatherapy at
4th and 12th weeks
Figure 1: Flowchart of the distribution of the cohort study.
cardiac parasympathetic activity [17, 18]. Frequency domain
measures are derived from spectral analysis of N-N intervals
andmaybeexpressedineitherabsoluteornormalizedterms.
Absolute terms including the total power (TP), the very-low-
frequency power (VLF: 0.00–0.04Hz), the low-frequency
power (LF: 0.04–0.015Hz), and the high-frequency power
(HF: 0.15–0.40Hz) were calculated using a 3-minute win-
dow. Normalized unit spectral power measures (HFnu,
LFnu) are derived from their absolute power equivalents
(HF, LF) over a normalizing denominator of the total power
(from which VLF has been subtracted) and multiplying by
100. Overall, VLF, HF, and HFnu represent parasympathetic
activity; LF and LFnu represent both sympathetic and
parasympathetic activity. Finally, the LF/HF or LFnu/HFnu
ratio is considered to reﬂect sympathovagal balance [17, 18].
2.4. Statistical Analysis. Categorical variables were compared
by Chi-square/Fisher’s exact test and nonparametric data on
HRV parameters at baseline, 1 month after treatment, and
after 3 months between the two groups they were compared
using the Mann-Whitney U-test. In addition, Wilcoxon
signed-rank tests were employed to analyze the HRV param-
eters before and after treatment in the experimental group.
Categorical data were represented by number (%) and non-
parametric data presented as median (interquartile range).
All statistical assessments were two-sided and evaluated at
the 0.05 level of signiﬁcant diﬀerence. Statistical analyses
were performed using SPSS 15.0 statistics software (SPSS
Inc., Chicago, Ill, USA).
3. Results
Amongtherandomizedparticipants,7(10.4%)didnotcom-
plete the study. In the experimental group, 29 of 34 patients
(85.3%) completed the study while 5 withdrew early, and
in the control group, 31 of 33 patients (93.9%) completed
the study while 2 withdrew from it. The demographics and
characteristics of study subjects are shown in Table 1.T h e r e
were no statistically signiﬁcant diﬀerences in demographics
and characteristics between the two groups (P>0.05).
Table 2 represents the comparison of HRV parameters in the
4th and 12th weeks of treatment in the experimental group.
In the 4th week, there were signiﬁcant diﬀerences in mean
HR, SDNN, RMSSD, and HF before and after aromatherapy
in the experimental group (P<0.05). In the 12th week, there
were signiﬁcantly declined mean HR and increased SDNN,
RMSSD, and HF after lavender inhalation (P<0.05).
The diﬀerences in the HRV parameters between the two
groups at baseline 1 month and 3 months after allocation are
shown in Figure 2, indicating a signiﬁcant diﬀerence in VLF
at the ﬁrst month after treatment between the experimental
and control groups (P = 0.040). The median VLF level in
experimentalgroupwassigniﬁcantlyhigherthanthoseinthe
control group. All the other HRV measurements, however,
did not show signiﬁcant diﬀerence between the lavender
aromatherapy and control group.
Changes in the Chinese Pittsburgh Sleep Quality Index
(CPSQI) scale of study subjects are shown in Figure 3.T h e
result indicates that statistically signiﬁcant decreases in the
total score before and after treatment were observed in the
experimental group (P<0.001). However, in the control
group,nosigniﬁcantdiﬀerencewasobservedacrossthesame
time period (P = 0.776). When the Mann-Whitney U-test
was used to compare the eﬀect of change in the CPSQI total
scorebeforetreatmentbetweenbothgroups,thedatashowed
a statistically signiﬁcant diﬀerence between the experimental
and control groups (−4.90 versus −0.26, P<0.001).
4. Discussion
We found a signiﬁcant decrease in mean HR and increases
in time domain analysis HRV parameters (SDNN, RMSDD)
after 20min of lavender inhalation. Moreover, HF is also
increased, and all these indices have been used to reﬂect
primarily parasympathetic inﬂuences [17, 18]. LF and LFnu
remain unchanged. As a result, the LFnu to HFnu ratio is
unchanged. LF has been shown to reﬂect both sympathetic
and parasympathetic inﬂuences, making the contributive
components of this measurement less clear [17, 18]. How-
ever, no change in LF and ratio of LFnu/HFnu infers that
there is no impact on sympathetic drive to the heart. Our
data demonstrated that lavender inhalation may have a
persistent short-term eﬀect on HRV with an increase in
the vagal tonic and a preserved sympathetic tone. We also
showed that 24 sessions of aromatherapy improve sleep
quality in women with insomnia up to 1 week after the end
of the intervention. The beneﬁcial eﬀect of HRV, however, is
not shown in the resting measurements after 4 and 12 weeks4 Evidence-Based Complementary and Alternative Medicine
Table 1: Demographics and characteristics of study subject between experimental and control groups (N = 67).
Variable Control group (n = 33) Experimental group (n = 34) P value
Age (years)1 51.09 ±3.73 50.85 ±3.73 0.796
Education, n (%)2
0.777 Below junior 6 (19.4) 5 (15.2)
High school 18 (58.1) 22 (66.7)
Above university 7 (22.6) 6 (18.2)
Employment, n (%)2
0.941 No 9 (27.3) 9 (26.5)
Yes 24 (72.7) 25 (73.5)
Marital status, n (%)2
1.000
Unmarried 2 (6.1) 3 (9.1)
Married 27 (81.8) 26 (78.8)
Divorce 3 (9.1) 2 (6.1)
Widow 1 (3.0) 2 (6.1)
Menopause, n (%)2
0.901 No 16 (48.5) 17 (50.0)
Yes 17 (51.5) 17 (50.0)
Regular exercise, n (%)2
0.675 No 11 (34.4) 13 (39.4)
Yes 21 (65.6) 20 (60.6)
Afternoon nap, n (%)2
0.938 No 21 (65.6) 22 (64.7)
Yes 11 (34.4) 12 (35.3)
Drinks coﬀee/tea, n (%)2
0.805 No 15 (45.5) 16 (48.5)
Yes 18 (54.5) 17 (51.5)
Drinks wine, n (%)2
0.183 No 28 (75.8) 30 (88.2)
Yes 5 (24.2) 4 (11.8)
Smoking, n (%)2
0.672 No 31 (93.9) 29 (87.9)
Yes 2 (6.1) 4 (12.1)
CPSQI-total3 9 (8, 12) 11 (9, 13) 0.100
Values are expressed as 1mean±standard deviation; 2number (percentage), and 3median (interquartile range). P Values are based on 1independent two-
sample t-test, 2Chi-square test and 3Mann-Whitney U-test.
of lavender aromatherapy in comparison with the control
group.
Prior investigations on the responses of ANS to olfactory
stimuli focused on the immediate correlation with subjective
mood changes [11, 19]. Saeki investigated the eﬀect of
footbath with or without the essential oil of lavender on
the ANS of young women [20]. Using spectral analysis, the
parasympathetic nerve activity increased signiﬁcantly during
both types of footbath. With the addition of essential oil
of lavender, there were positive eﬀects on HRV 10min after
the footbath was complete [20]. Bradley et al. demonstrated
that after oral administration of 200µL lavender essential oil,
the amount of linalool was detectable in the blood stream
within 10min and reached a peak at about 30min and was
no longer detectable by 45min [21]. Our result conﬁrmed
the above observation of the consistently short-term eﬀect
of lavender inhalation on the modulation of HRV. It has
been suggestedfrom animal studies that lavender’s anxiolytic
eﬀectsmaybecomemorepotentwithchronicadministration
(2 weeks) in female rats similar to that of the anxiolytic
diazepam[22].Ourdatadidnotsupportthelong-termeﬀect
of lavender on the modulation of HRV; thus, the hypothesis
that chronic application of lavender aromatherapy would
improve autonomic modulations could not be proved.
It has been suggested that insomnia is associated with
inappropriate physiological arousal [23]. Patients with pri-
mary insomnia have been found to have increased high-
frequency EEG activation, abnormal hormone secretion,
increased whole body and brain metabolic activation, and
elevated HR and sympathetic nervous system activation
during sleep [23]. The physiological hyperarousal has been
evidenced by increased LF and decreased HF across all
sleep stages; both measures reﬂect elevated sympathetic
nervous system activity [24, 25]. A reduced nocturnal HRVEvidence-Based Complementary and Alternative Medicine 5
Table 2: Comparison of HRV parameters in the 4th and 12th weeks before and after lavender fragrance stimuli in the experimental group.
Variable Before inhalation After inhalation P value
HR (bpm)
4th week 72.5 (65, 77) 68 (64, 72) <0.00∗
12th week 77 (73, 88) 74 (67, 82) <0.00∗
SDNN (ms)
4th week 34.25 (22.84, 45.99) 35.32 (30.07, 46.80) 0.007∗
12th week 23.60 (20.39, 39.07) 34.52 (22.74, 40.95) 0.011∗
RMSSD (ms)
4th week 24.58 (15.97, 36.75) 28.68 (23.27, 38.93) 0.003∗
12th week 18.26 (14.52, 27.29) 23.25 (19.06, 35.33) 0.031∗
TP (ms2)
4th week 804.5 (461, 1443) 887.5 (610, 1896) 0.132
12th week 497 (236, 1211) 781 (310, 1228) 0.299
VLF (ms2)
4th week 279.88 (179.63, 654.97) 418.41 (206.44, 842.06) 0.228
12th week 224.23 (106.74, 461.38) 318.36 (121.96, 489.44) 0.468
LF (ms2)
4th week 213.74 (94.89, 499.63) 284.64 (102.17, 557.60) 0.602
12th week 114.02 (53.36, 454.59) 202.22 (63.92, 344.73) 0.652
HF (ms2)
4th week 140.66 (74.88, 270.39) 183.56 (104.89, 341.60) 0.039∗
12th week 102.42 (48.33, 183.01) 153.12 (95.31, 236.38) 0.036∗
LFnu (%)
4th week 61.37 (39.65, 75.22) 62.17 (41.15, 75.46) 0.663
12th week 62.75 (52.63, 66.82) 50.54 (39.02, 75.26) 0.065
HFnu (%)
4th week 38.63 (24.78, 60.35) 37.83 (24.54, 58.85) 0.663
12th week 37.26 (33.18, 47.37) 49.46 (24.74, 60.98) 0.065
LFnu/HEnu (ratio)
4th week 1.59 (0.66, 3.04) 1.65 (0.70, 3.07) 0.912
12th week 1.68 (1.11, 2.01) 1.02 (0.64, 3.04) 0.134
Values are expressed as median (interquartile range). ∗indicates a signiﬁcant diﬀerence before and after treatment using Wilcoxon signed-rank test (P<0.05).
as indicated by a lower wake-to-sleep HR reduction and
lower SDNN has been shown in a previous report on
polysomnographically determined insomnia patients [26].
Additionally, reduced parasympathetic activity as indicated
by decreased HF of HRV, as well as decreased RMSSD,
was also demonstrated in insomnia patients with objectively
determined short sleep duration [26]. We demonstrated
that lavender aromatherapy decreases HR and increases
HF, SDNN, and RMSSD during a period of 30min. It
might suggest that increases in HRV are an indication that
lavenderinteractedwiththeparasympatheticnervoussystem
to modulate anxiety and aid in improving self-reported
sleep quality. It has been shown that “falling asleep” is
preceded by changes in ANS signaling, notably an increase
in parasympathetic tone and reduction of sympathetic drive
with a concomitant reduction in the HR and an increase in
HRV [24, 25, 27]. These changes are thought to be linked
to the restorative functions of the parasympathetic nervous
system and may be instrumental in the subjective experience
of sleep as refreshing [27]. However, it remains unclear
whether the change in sympathovagal balance reﬂects an
inﬂuence of sleep mechanisms over the ANS, or the reverse
[25].
On the basis of a comprehensive review, Herz con-
cluded that the perceived quality of the odor was the
most relevant factor accounting for individual responses to
aromatherapy [11]. Cognitive or psychological mechanisms
of odor transduction may confound pharmacological eﬀects
of aromatherapy in humans [19, 28]. Recently developed
neuroimaging techniques provide new insights into the role
of brain in correlation with autonomic modulation [29,
30]. In a study involving a combination of continuous
electrocardiographic (ECG) monitoring and positron emis-
sion tomography (PET) examination, Duan and colleagues
tried to detect changes of ANS and localization of cerebral
activity during lavender aromatic immersion [30]. They
found increases in the parasympathetic tone after the
lavender fragrance stimulus increases in the HF component
and decreases in the LF/HF. Simultaneous measurement
with positron emission tomography (PET) suggested that6 Evidence-Based Complementary and Alternative Medicine
Baseline
H
R
(
b
p
m
)
110
100
90
80
70
60
50
1st month after
treatment
After 3 months Baseline 1st month after
treatment
S
D
N
N
(
m
s
)
100
80
60
40
20
0
After 3 months
Baseline 1st month after
treatment
R
M
S
S
D
(
m
s
)
120
100
80
60
40
20
0
After 3 months
2000
1500
1000
500
0
Baseline 1st month after
treatment
V
L
F
(
m
s
2
)
∗
A f t e r3m o n t h s
2000
1500
1000
500
0
Baseline 1st month after
treatment
L
F
(
m
s
2
)
After 3 months
1000
800
600
400
200
0
Baseline 1st month after
treatment
H
F
(
m
s
2
)
A f t e r3m o n t h s
L
F
n
u
(
%
)
100
80
60
40
20
0
Baseline 1st month after
treatment
After 3 months
H
F
n
u
(
%
)
100
80
60
40
20
0
Baseline 1st month after
treatment
After 3 months
Figure 2: Continued.Evidence-Based Complementary and Alternative Medicine 7
L
F
n
u
/
H
F
n
u
(
r
a
t
i
o
)
8
6
4
2
0
Baseline 1st month after
treatment
Experimental group
Control group
Group
After 3 months
Figure 2: Comparison of HRV parameters during the study period. ∗indicates a signiﬁcant diﬀerence in VLF between the two groups at the
ﬁrst month after treatment using Mann-Whitney U-test (P<0.05).
15
10
5
0
Control group Experimental group
C
h
a
n
g
e
s
i
n
t
h
e
C
P
S
Q
I
t
o
t
a
l
s
c
o
r
e
f
r
o
m
b
a
s
e
l
i
n
e
a
P<0.001∗
Figure 3: Changes in the Chinese Pittsburgh Sleep Quality Index
(CPSQI) total score from baseline in each group. ∗indicates a
signiﬁcant diﬀerence between the two groups using Mann-Whitney
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lavender aromatic treatment induced not only relaxation but
also increased arousal level in these subjects [30]. Whether
the eﬀect of increasing HRV from lavender aromatherapy is
through the psychological process or direct pharmacological
eﬀect could not be determined from this study. The lack
of chronic eﬀect on the modulation of HRV as shown
from our data indicates that further investigation needs
to be conducted on the interaction of psychological with
physiological mechanisms.
The strengths of this study involved consecutive partici-
pants with a longitudinal followup. We applied a standard-
ized procedure to deliver the lavender odor and recruited
suﬃcient and representative participant populations to be
tested. However, our study also has several limitations. First,
polysomnography was not included to monitor speciﬁc sleep
stages. The recorded diﬀerences in HRV data could not be
related to speciﬁc sleep stages and were rather related to gen-
eral sleep quality. Second, the participants of this study were
a mixture of premenopausal and postmenopausal women
with diﬀerent hormone status. Although prior ﬁndings are
not entirely consistent, low endogenous estradiol states have
been associated with reduced cardiac vagal control [31,
32]. Reproductive hormones were not measured in this
investigation; therefore, their role cannot be determined
here. Finally, there is no placebo eﬀect in the control group.
It appears that participant expectations regarding likely
eﬃcacy may have impacts on the outcomes of aromatherapy
that have been reported [28]. To minimize this bias, we
provided a health education program regarding good sleep
hygiene in both groups. Those with no intervention in the
control group were oﬀered the same intervention procedure
if they wanted. However, further research on the normal
sleepers in combination with appropriate control needs to be
conducted to clarify the eﬃcacy of lavender aromatherapy in
the management of insomnia or other health issues.
5. Conclusions
After 12 weeks of lavender aromatherapy, midlife women
with insomnia have improvement in the quality of their
sleep. Increased HRV modulations with a lower resting HR
as well as a higher SDNN, RMSDD, and HF were observed
shortly after lavender inhalation. Lavender aromatherapy
does not appear to confer beneﬁt on HRV in the long-term
followup.
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